Events & Presentations
-
Seminar on local production and access to medical products
The World Health Organization and the European Parliament Working Gorup on innovation, access to medicines and poverty-related diseases inviteds you to a seminar on local production and access to medical products Wednesday, 7 December 2011 9am to 12:30pm Room ASP 3GS, European Parliament Building, Brussels
Last updated 7 December 2011
www.msfaccess.org/content/seminar-local-production-and-access-medical-products -
Revising TRIPS for Public Health: Can TRIPS be reformed to meet public health needs?
Last updated 1 November 2011
www.msfaccess.org/content/revising-trips-public-health-can-trips-be-reformed-meet-public-health-needs -
Why a Financial Transaction Tax should not drift away from benefiting international development and health
Innovative Financing Mechanisms for Health : Why Financial Transaction Tax (FTT) should not drift away from benefiting international development and health ? Lunch Debate Hosted by David Martin MEP, Chair of the EP Working Group on Innovation, Access to Medicines and Poverty-Related Diseases European Parliament - Brussels . Room JAN 4Q2 18 October 2011 / 12.15 - 14.30$
Last updated 18 October 2011
www.msfaccess.org/content/why-financial-transaction-tax-should-not-drift-away-benefiting-international-development-and -
Innovative Financing Mechanisms for Health: Why Financial Transaction Tax (FTT) should not drift away from benefiting international development and health
SAVE THE DATE! David Martin MEP, Chair of the EP Working Group on Innovation, Access to Medicines and Poverty-Related Diseases cordially invites you to: Innovative Financing Mechanisms for Health: Why Financial Transaction Tax (FTT) should not drift away from benefiting international development and health Lunch Debate European Parliament, Brussels Room P3C050 18 October 2011, 12.00 – 14.00
Last updated 29 September 2011
www.msfaccess.org/content/innovative-financing-mechanisms-health-why-financial-transaction-tax-ftt-should-not-drift -
Resetting the agenda according to the needs: Antiretroviral sequencing or the best use of existing and promising pipeline HIV drugs.
Médecins Sans Frontières (MSF) with participation from Ensemble pour un Solidarité Thérapeutique Hospitaliere en Réseau (Esther) and Solidarité Thérapeutique & Initiatives contra le SIDA (Sothis) convened a meeting of experts in HIV treatment to look at antiretroviral (ARV) regimens and strategies to support the further scale up treatment and long-term sustainability in resource limited settings (RLS).
Last updated 22 September 2011
www.msfaccess.org/content/resetting-agenda-antiretroviral-sequencing -
Event: Getting the Balance Right, Global Immunisation Vision & Strategy
Briefing to the 64th World Health Assembly delegationsWednesday 18 May 2011, 17:30- 19:30Room IX, Palais des Nations
Last updated 27 May 2011
www.msfaccess.org/content/event-getting-balance-right-global-immunisation-vision-strategy -
Medical Innovation Prizes Instead of Monopolies
“Medical Innovation Prizes instead of Monopolies” Innovation Inducement Prizes that de-link the cost of R&D from the price of products to increase access to medicines for patients living in Europe and developing countries Date: May 31, 2011 Time: 09.30 – 13.00 Location: Room: Paul Henri Spaak 1A 002, European Parliament. Brussels
Last updated 19 May 2011
www.msfaccess.org/content/medical-innovation-prizes-instead-monopolies -
Drug-resistant TB and TB-HIV co-infection on the EU’s Doorstep: The example of Ukraine
European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases Putting Patients’ Needs First:Supporting better innovation, access to medicines and healthcare to combat poverty related diseases Drug-resistant TB and TB-HIV co-infection on the EU’s Doorstep: The example of UkraineWhat can the EU do to curb the threat? Roundtable European Parliament, Brussels
Last updated 13 April 2011
www.msfaccess.org/content/drug-resistant-tb-and-tb-hiv-co-infection-eu%E2%80%99s-doorstep-example-ukraine -
EU-India Free Trade Agreement: What future for patients in developing countries?
ALDE Group & European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases HEARING EU-India Free Trade Agreement: What future for patients in developing countries? Hosted by MEP Niccolò Rinaldi and MEP Fiona Hall European Parliament, Brussels Room PHS4B001 10th February 14,30-18,00
Last updated 10 February 2011
www.msfaccess.org/content/eu-india-free-trade-agreement-what-future-patients-developing-countries -
World AIDS Day 2010
Reduced Funding & New Barriers to Affordable Medicines Threaten Progress on AIDS On World AIDS Day, MSF is speaking out about the double blow being dealt to HIV/AIDS treatment. A stagnation in donor funding, coupled with looming trade policies that will create serious barriers in getting affordable generic medicines to patients, are threatening recent gains in HIV/AIDS treatment.
Last updated 25 November 2010
www.msfaccess.org/content/world-aids-day-2010
